| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gallagher Duncan | Director | C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN | /s/Benjamin Landry, as Attorney-in-Fact | 2025-06-03 | 0001780880 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HCAT | Common Stock | Award | $0 | +4.08K | +5.59% | $0.00 | 77.1K | Jun 1, 2025 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents an award of the Issuer's restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and in accordance with the terms of Issuer's Non-Employee Director Compensation Policy, 100% of such RSUs vested on June 1, 2025. |